Does DABIGATRAN ETEXILATE Cause Haemoglobin decreased? 382 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 382 reports of Haemoglobin decreased have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 1.0% of all adverse event reports for DABIGATRAN ETEXILATE.
382
Reports of Haemoglobin decreased with DABIGATRAN ETEXILATE
1.0%
of all DABIGATRAN ETEXILATE reports
61
Deaths
321
Hospitalizations
How Dangerous Is Haemoglobin decreased From DABIGATRAN ETEXILATE?
Of the 382 reports, 61 (16.0%) resulted in death, 321 (84.0%) required hospitalization, and 68 (17.8%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 382 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN ETEXILATE Cause?
Gastrointestinal haemorrhage (4,081)
Cerebrovascular accident (2,175)
Fall (1,786)
Ischaemic stroke (1,581)
Anaemia (1,412)
Haemorrhage (1,324)
Death (1,025)
Rectal haemorrhage (964)
Cerebral haemorrhage (946)
Upper gastrointestinal haemorrhage (861)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which DABIGATRAN ETEXILATE Alternatives Have Lower Haemoglobin decreased Risk?
DABIGATRAN ETEXILATE vs DABRAFENIB
DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB
DABIGATRAN ETEXILATE vs DACARBAZINE
DABIGATRAN ETEXILATE vs DACLATASVIR
DABIGATRAN ETEXILATE vs DACLIZUMAB